Level C· Early human research exploring benefitsCase Report / SeriesEurope PMCOpen access

Taking Face Lifts to the Next Level: Case Series Reflecting the Safety and Efficacy of Plasma Resurfacing with Face and Neck Lifts

Lacerna Kimbrell M.

Case Report / Series with a reported sample of 93 on Scar, Skin Aging, Facial Rejuvenation, published in Plast Reconstr Surg (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Plast Reconstr Surg (2026)
Reported sample size
93
Source database
Europe PMC
PMID
41218171
PMCID
PMC13290035
DOI
10.1097/prs.0000000000012596

Abstract (original English)

Background Deep facial skin resurfacing with plasma technology is known to produce superior correction of deep rhytids and photoelastosis. When combined with a rhytidectomy, total facial rejuvenation can be achieved in a single surgical session and recovery period. Methods A single surgeon's experience (2017 to 2025) is presented involving 96 consecutive patients (93 women and 3 men; age range, 48 to 86 years) who underwent a single-session combination of face and neck lifts, full-face fat grafting, and full-face deep plasma skin resurfacing. Helium plasma radiofrequency was used in 84 patients, and nitrogen radiofrequency plasma was used in 12 patients. A subset of 20 patients underwent additional computerized skin analysis preoperatively and at 90 days postoperatively. The longest follow-up was 6 years. Results Computerized analysis showed decreased upper cutaneous lip height (0.25 to 2.47 mm; average, 1.26 mm), decreased skin age (1 to 9 years; average, 4.27 years), improved elasticity (1 to 20 years; average, 9.81 years), rhytid reduction (1 to 22 years; average, 7.36 years), and ultraviolet spot reduction (1 to 9 years; average, 4.54 years). The 4 complications (4 of 96 patients [4.1%], all in the helium radiofrequency group) included transient cellulitis (1 patient) and hypertrophic scarring (3 patients). No skin necrosis occurred. Results demonstrated significant correct

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
FaceNeckHumansPostoperative ComplicationsTreatment OutcomeRejuvenationRhytidoplastyFollow-Up StudiesSkin AgingAged

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research